Previous 10 | Next 10 |
home / stock / bhc:cc / bhc:cc news
LAVAL, QC / ACCESSWIRE / July 13, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) will release its second-quarter financial results on Thursday, Aug. 3, 2023. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EDT to discuss the results and provide a business update....
Oral Health Care Companies Celebrate the 100 th ADHA Conference by Highlighting New Data for the Treatment of Periodontal Disease LAVAL, QC / ACCESSWIRE / July 7, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) and its oral health care business, OraPharma, today announced its presence at...
LAVAL, QC / ACCESSWIRE / July 7, 2023 / Bausch Health Companies Inc. (NYSE/TSX:BHC) and KKR today announced that Bausch Receivables Funding LP, an Ontario limited partnership and wholly-owned subsidiary of Bausch Health, has entered into a $600 million non-recourse financing facility with KKR an...
2023-07-06 16:01:08 ET Summary Bausch + Lomb Corporation was spun out of Bausch Health Companies Inc. this year - after years of speculation - and the new entity is an eye disease specialist. The parent company owns nearly 90% of the spun-out company's stock. Bausch + Lomb ann...
U.S. markets were shuttered for the Fourth of July. They'll resume business Wednesday.
LAVAL, QC / ACCESSWIRE / June 30, 2023 / Bausch + Lomb Corporation (NYSE/TSX:BLCO), a subsidiary of Bausch Health Companies Inc. (NYSE/TSX:BHC), announced that it has entered into a definitive agreement with Novartis to acquire XIIDRA® (lifitegrast ophthalmic solution) 5%, a non-steroid eye...
2023-06-30 07:55:08 ET Bausch + Lomb Corporation ( BLCO ) is set to pay $1.75B to acquire Xiidra, a dry-eye treatment from Novartis ( NVS ), The Wall Street Journal reported Friday, citing people familiar with the matter. The deal, the first major transaction under Bausch + Lo...
The S&P 500 was little changed Wednesday as traders digested the latest commentary on the pace of future monetary policy from Federal Reserve Chair Jerome Powell. The Dow Jones Industrials dipped 74.08 points to close out Wednesday at 33,852.66. The S&P 500 handed back 1.55 points...
2023-06-25 12:00:43 ET The pharmaceutical industry is caught between a rock and a hard place. If the pricing concerns sparked by the recently enacted Inflation Reduction Act are not enough, the Federal Trade Commission has stepped up scrutiny over merger deals, hurting prospects for a buyou...
2023-06-20 21:39:46 ET Summary John Paulson's 13F portfolio value increased by around 8% from approximately $1.11B to $1.20B in Q1 2023. The top five positions in the portfolio are Bausch Health, Brightsphere Investment Group, Novagold, Perpetua Resources, and Horizon Therapeutics...
News, Short Squeeze, Breakout and More Instantly...
Bausch Health Companies Inc. Company Name:
BHC:CC Stock Symbol:
TSXC Market:
Bausch Health Companies Inc. Website:
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charhon ("JJ") will join the Company as Chief Financial Officer on August 19, 2024. JJ has over 25 ...
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business...
The S&P 500 rose to a new high on Friday, putting the broad-market index on track for yet another weekly gain during the holiday-shortened trading week. The tech-heavy NASDAQ Composite also hit a new high. The Dow Jones Industrials climbed 67.87 points to end Friday at 39,375.87. The ...